SUPERNUS PHARMACEUTICALS INC (SUPN) — insider trading
Health Care · NASDAQ
SUPERNUS PHARMACEUTICALS INC (SUPN) has 80 reported SEC Form 4 insider transactions in our data, including 15 open-market sales among the most recent 80 (latest 2026-08-12).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Option exercise / conversion (derivative) | 1,250 | — | $0 | Form 4 |
| 2026-08-12 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Shares withheld for taxes / exercise cost | 604 | $46.57 | $28.1K | Form 4 |
| 2026-08-12 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Option exercise / conversion | 1,250 | — | $0 | Form 4 |
| 2026-08-12 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Option exercise / conversion (derivative) | 1,650 | — | $0 | Form 4 |
| 2026-08-12 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Shares withheld for taxes / exercise cost | 797 | $46.57 | $37.1K | Form 4 |
| 2026-08-12 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Option exercise / conversion | 1,650 | — | $0 | Form 4 |
| 2026-08-12 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 2,500 | — | $0 | Form 4 |
| 2026-08-12 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Shares withheld for taxes / exercise cost | 1,158 | $46.57 | $53.9K | Form 4 |
| 2026-08-12 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 2,500 | — | $0 | Form 4 |
| 2026-08-12 | Rubin Jonathan | Officer (SVP, Chief Medical Officer) | Option exercise / conversion (derivative) | 750 | — | $0 | Form 4 |
| 2026-08-12 | Rubin Jonathan | Officer (SVP, Chief Medical Officer) | Shares withheld for taxes / exercise cost | 363 | $46.57 | $16.9K | Form 4 |
| 2026-08-12 | Rubin Jonathan | Officer (SVP, Chief Medical Officer) | Option exercise / conversion | 750 | — | $0 | Form 4 |
| 2026-08-12 | Khattar Jack A. | Director, Officer (President, CEO) | Option exercise / conversion (derivative) | 29,849 | — | $0 | Form 4 |
| 2026-08-12 | Khattar Jack A. | Director, Officer (President, CEO) | Shares withheld for taxes / exercise cost | 12,642 | $46.57 | $588.7K | Form 4 |
| 2026-08-12 | Khattar Jack A. | Director, Officer (President, CEO) | Option exercise / conversion | 29,849 | — | $0 | Form 4 |
| 2026-07-29 | Rubin Jonathan | Officer (SVP, Chief Medical Officer) | Grant / award / vesting (derivative) | 750 | — | $0 | Form 4 |
| 2026-07-29 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Grant / award / vesting (derivative) | 2,500 | — | $0 | Form 4 |
| 2026-07-29 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Grant / award / vesting (derivative) | 1,650 | — | $0 | Form 4 |
| 2026-07-29 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Grant / award / vesting (derivative) | 1,250 | — | $0 | Form 4 |
| 2026-07-29 | Khattar Jack A. | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 29,849 | — | $0 | Form 4 |
| 2026-03-18 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 7,250 | — | $0 | Form 4 |
| 2026-03-18 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Open-market sale | 412 | $50.48 | $20.8K | Form 4 |
| 2026-03-18 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Open-market sale | 6,838 | $49.55 | $338.8K | Form 4 |
| 2026-03-18 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 7,250 | $39.40 | $285.6K | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 12,250 | — | $0 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 22,750 | — | $0 | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Open-market sale | 22,290 | $50.73 | $1.13M | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Open-market sale | 27,710 | $49.95 | $1.38M | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 15,000 | $38.60 | $579.0K | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 12,250 | $36.75 | $450.2K | Form 4 |
| 2026-03-17 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 22,750 | $39.40 | $896.4K | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 18,000 | — | $0 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 4,250 | — | $0 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion (derivative) | 22,750 | — | $0 | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Open-market sale | 15,886 | $50.49 | $802.1K | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Open-market sale | 34,114 | $50.18 | $1.71M | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 5,000 | $27.94 | $139.7K | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 18,000 | $32.20 | $579.6K | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 4,250 | $29.61 | $125.8K | Form 4 |
| 2026-03-16 | Bhatt Padmanabh P. | Officer (Sr. VP of IP, CSO) | Option exercise / conversion | 22,750 | $36.75 | $836.1K | Form 4 |
| 2026-03-13 | Khattar Jack A. | Director, Officer (President, CEO) | Open-market sale | 120 | $51.75 | $6.2K | Form 4 |
| 2026-03-13 | Khattar Jack A. | Director, Officer (President, CEO) | Open-market sale | 10,742 | $51.00 | $547.8K | Form 4 |
| 2026-03-13 | Khattar Jack A. | Director, Officer (President, CEO) | Open-market sale | 24,138 | $50.09 | $1.21M | Form 4 |
| 2026-03-13 | Khattar Jack A. | Director, Officer (President, CEO) | Other acquisition or disposition | 12,500 | — | — | Form 4 |
| 2026-03-13 | Khattar Jack A. | Director, Officer (President, CEO) | Other acquisition or disposition | 12,500 | — | — | Form 4 |
| 2026-03-12 | Hudson Frederick M. | Director | Open-market sale | 5,369 | $50.61 | $271.7K | Form 4 |
| 2026-03-10 | Horich William Todd | Officer (SVP, Commercial Operations) | Open-market sale | 4,439 | $55.00 | $244.1K | Form 4 |
| 2026-03-09 | Horich William Todd | Officer (SVP, Commercial Operations) | Open-market sale | 4,438 | $54.00 | $239.7K | Form 4 |
| 2026-03-09 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Open-market sale | 1,623 | $53.65 | $87.1K | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Option exercise / conversion (derivative) | 1,125 | — | $0 | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Option exercise / conversion (derivative) | 3,750 | — | $0 | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Option exercise / conversion (derivative) | 2,625 | — | $0 | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Shares withheld for taxes / exercise cost | 521 | $54.73 | $28.5K | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Option exercise / conversion | 1,125 | — | $0 | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Shares withheld for taxes / exercise cost | 1,718 | $54.73 | $94.0K | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Option exercise / conversion | 3,750 | — | $0 | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Shares withheld for taxes / exercise cost | 1,216 | $54.73 | $66.6K | Form 4 |
| 2026-03-06 | Horich William Todd | Officer (SVP, Commercial Operations) | Option exercise / conversion | 2,625 | — | $0 | Form 4 |
| 2026-03-06 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Option exercise / conversion (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-03-06 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Option exercise / conversion (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-03-06 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Shares withheld for taxes / exercise cost | 1,450 | $54.73 | $79.4K | Form 4 |
| 2026-03-06 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Option exercise / conversion | 3,000 | — | $0 | Form 4 |
| 2026-03-06 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Shares withheld for taxes / exercise cost | 1,433 | $54.73 | $78.4K | Form 4 |
| 2026-03-06 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Option exercise / conversion | 3,000 | — | $0 | Form 4 |
| 2026-03-06 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Option exercise / conversion (derivative) | 3,750 | — | $0 | Form 4 |
| 2026-03-06 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Shares withheld for taxes / exercise cost | 1,793 | $54.73 | $98.1K | Form 4 |
| 2026-03-06 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Option exercise / conversion | 3,750 | — | $0 | Form 4 |
| 2026-03-06 | Khattar Jack A. | Director, Officer (President, CEO) | Option exercise / conversion (derivative) | 38,640 | — | $0 | Form 4 |
| 2026-03-06 | Khattar Jack A. | Director, Officer (President, CEO) | Shares withheld for taxes / exercise cost | 16,574 | $54.73 | $907.1K | Form 4 |
| 2026-03-06 | Khattar Jack A. | Director, Officer (President, CEO) | Option exercise / conversion | 38,640 | — | $0 | Form 4 |
| 2026-03-06 | GEMAYEL GEORGES | Director | Option exercise / conversion (derivative) | 7,905 | — | $0 | Form 4 |
| 2026-03-06 | GEMAYEL GEORGES | Director | Open-market sale | 8,787 | $53.00 | $465.7K | Form 4 |
| 2026-03-06 | GEMAYEL GEORGES | Director | Option exercise / conversion | 7,905 | $25.30 | $200.0K | Form 4 |
| 2026-03-05 | GEMAYEL GEORGES | Director | Open-market sale | 10,000 | $53.71 | $537.1K | Form 4 |
| 2026-02-28 | Mottola Frank | Officer (SVP, Chief Tech. Ops. Officer) | Grant / award / vesting (derivative) | 3,750 | — | $0 | Form 4 |
| 2026-02-28 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-02-28 | DEC TIMOTHY C | Officer (Senior Vice-President & CFO) | Grant / award / vesting (derivative) | 3,000 | — | $0 | Form 4 |
| 2026-02-28 | Khattar Jack A. | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 38,640 | — | $0 | Form 4 |
Ask the chat about SUPN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: SUPERNUS PHARMACEUTICALS INC (SUPN).
Last updated 2026-08-12 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.